SEJONG MEDICAL Co.Ltd.

At a glance

SEJONG MEDICAL Co.Ltd. filed 51 disclosures in the last 12 months, including 4 5% holder and 3 insider. The most recent key filing was on Jul 31: A major holder's stake fell from 55.42% to 55.38% (conversion/exercise).

Revenue for 2025 was ₩18.5B, down 2.2% on 2024. Operating margin was 12.2% against -2.5% a year earlier. Debt was 164% of equity at year end. The latest interim report (2026 H1) shows revenue of ₩9.8B and operating profit of ₩2.3B.

The 2025 annual report lists 106 employees with an average tenure of 6.3 years and average pay of ₩46.6M, #1892 of 2,191 listed companies by average pay. Its 4 directors and auditors were paid ₩107.8M each on average. It paid no cash dividend for 2025. (주)비에스제이홀딩스 and related parties held 21.01% at year end.

Of 4 recent 5%+ holder reports, 1 raised and 2 cut a stake; the largest stake reported was 55.42% on Feb 13.

From the 2025 annual report

Staff: 106 (30 men, 76 women), of whom 0 on fixed-term contracts. Total pay for the year: ₩4.9B. Directors and auditors: 4, paid ₩431.3M in total.

No cash dividend was paid for 2025.

Largest shareholder

(주)비에스제이홀딩스 holds 21.01%; with 0 related parties the group holds 21.01% of common shares at year end (from 6.85% at the start of the year).

Auditor: 현대회계법인 · opinion: Unqualified. The report includes an emphasis of matter.

Source: 2025 annual business report (DART). How figures are combined

Financial summary

5%+ holder reports